go back

North Dakota rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $489,779 · 10th–90th $489,779–$870,9640%50%90th$489,779Professionalmedian $489,779 · 10th–90th $489,779–$616,5950%50%90th$489,779$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $870,963.59
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $616,595.00
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$457,088.19 / $467,735.14 / $588,843.66
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $758,577.58 / $1,548,816.62
Medica
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$1,000,000.00 / $1,000,000.00 / $1,000,000.00
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$537,031.80 / $537,031.80 / $537,031.80
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$363,078.05 / $467,735.14 / $741,310.24